Hexagon Bio Raises $62 Million Series C Financing to Advance HEX-360 into the Clinic and Expand Pipeline of Antibody-Drug Conjugates with Novel Payload Mechanisms

The post Hexagon Bio Raises $62 Million Series C Financing to Advance HEX-360 into the Clinic and Expand Pipeline of Antibody-Drug Conjugates with Novel Payload Mechanisms appeared first on Hexagon .